Scott Terrillion is Secretary at Cara Therapeutics, Inc. (CARA). They have made 4 open-market trades across 1 company since 2018, most recently 2025-02-28.
CIK 0001706426
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CARA | 7,190 | $38K |
Shares reported on the most recent Form 4, priced at the 2025-03-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CARA | SELL · 10b5-1 | 2025-02-28 | 2025-03-04 | $4.76 | $776 | +19.3% | +15.1% | N/A |
| CARA | SELL · 10b5-1 | 2024-04-05 | 2024-04-09 | $0.83 | $2K | -19.9% | -7.9% | -65.5% |
| CARA | SELL · 10b5-1 | 2024-02-29 | 2024-03-04 | $0.89 | $3K | -11.0% | +2.6% | -23.1% |
| CARA | SELL · 10b5-1 | 2023-06-23 | 2023-06-27 | $3.51 | $9K | -22.2% | -10.2% | -50.1% |
| CARA | SELL · 10b5-1 | 2023-04-04 | 2023-04-06 | $4.91 | $12K | -8.7% | -7.0% | -37.8% |
| CARA | SELL | 2023-03-03 | 2023-03-07 | $9.71 | $121K | -11.5% | -25.4% | -48.9% |
| CARA | SELL · 10b5-1 | 2023-02-08 | 2024-02-12 | $0.53 | $4K | +56.2% | +49.7% | +29.1% |
| CARA | SELL · 10b5-1 | 2022-12-21 | 2022-12-23 | $11.27 | $29K | +4.3% | +15.3% | -50.6% |
| CARA | SELL · 10b5-1 | 2022-04-01 | 2022-04-05 | $11.91 | $20K | +5.5% | -32.9% | -26.8% |
| CARA | SELL · 10b5-1 | 2022-03-03 | 2022-03-04 | $11.38 | $20K | +9.7% | +17.6% | -21.2% |
| CARA | SELL · 10b5-1 | 2022-02-25 | 2022-03-01 | $10.29 | $20K | +22.5% | +23.1% | -15.7% |
| CARA | SELL · 10b5-1 | 2021-08-30 | 2021-09-01 | $14.20 | $25K | -8.6% | -4.7% | -17.6% |
| CARA | SELL | 2021-03-05 | 2021-03-08 | $17.98 | $111K | +5.8% | +46.7% | -25.5% |
| CARA | SELL | 2021-02-25 | 2021-02-25 | $19.33 | $155K | -5.3% | +1.5% | -30.9% |
| CARA | SELL · 10b5-1 | 2020-12-30 | 2020-12-30 | $15.30 | $30K | +11.5% | +22.0% | +34.3% |
| CARA | SELL · 10b5-1 | 2020-04-21 | 2020-04-21 | $15.56 | $42K | -12.1% | -1.7% | +10.2% |
| CARA | SELL | 2019-12-04 | 2019-12-04 | $17.05 | $68K | +1.2% | -10.5% | -11.8% |
| CARA | SELL · 10b5-1 | 2019-05-29 | 2019-05-30 | $21.38 | $49K | -5.4% | +6.8% | +9.8% |
| CARA | SELL · 10b5-1 | 2018-12-28 | 2019-01-02 | $12.51 | $39K | +3.8% | +3.7% | +34.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.